James F. Young, Director at NOVAVAX INC (NVAX), sold 3,750 shares at $144.16 ($541K) on 2021-12-31, disclosed to the SEC on 2022-01-04.
Open-market sale of $541k NVAX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NVAX | SELL | 2024-06-21 | $190K | — | Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2021-03-25 | $4.6M | — | Filing → |